Srini Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad - 500 033, Telangana, India, established in 1995.
1995 Hyderabad - 500 033, Telangana, India Active
Last Updated:
Access Report
About Srini Pharmaceuticals Private Limited

Srini Pharmaceuticals Private Limited, a active private limited company, was established on 24 February 1995 in Hyderabad - 500 033, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24231TG1995PTC019543. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.70 Cr and a paid-up capital of ₹2.36 Cr.

Formerly known as Srini Pharmaceuticals Limited, Srini Pharmaceauticals Limited. It upholds a compliant status. Employing 436 professional, Its leadership includes Chinnapa Reddy Tera (Managing Director), Ravali Reddy Tera (Whole-Time Director). Past directors included Padiyath Mohammed Akbarali, Rajesh Kumar Goel, Robert Craig Baxter. It holds ₹120.11 Cr open charges and ₹80.58 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2024. It is based at 8-2-293/82/F/10Plot No 10, Type - C Road No 8, Film Nagar, Hyderabad - 500 033, Telangana.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231TG1995PTC019543

  • Registration Number

    019543

  • Incorporation Date

    24 February 1995

  • Authorized Capital

    ₹2.70 Cr

  • Paid-Up Capital

    ₹2.36 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.70 Cr
  • Paid Up Capital ₹ 2.36 Cr
  • Company Age 31 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 120.11 Cr
  • Satisfied Charges ₹ 80.58 Cr
  • Revenue Growth **** -18.31%
  • Profit Growth **** -536.98%
  • Ebitda **** -569.37%
  • Net Worth -44.78%
  • Total Assets -14.07%
Company report

Srini Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Srini Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Srini Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Chinnapa Reddy Tera Managing Director 06 Oct 1997 Current
Ravali Reddy Tera Whole-Time Director 26 Dec 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 08 May 2014 Past
Pramod Abcsdd Director 31 Mar 2018 Past
Pramod Abcsdd Nominee Director 15 Sep 2010 Past
Pramod Abcsdd Nominee Director 26 Oct 2009 Past
Pramod Abcsdd Director 08 May 2018 Past
Pramod Abcsdd Nominee Director 26 Jun 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Srini Pharmaceuticals.

Srini Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 18.31% decrease. The company also saw a substantial fall in profitability, with a 536.98% decrease in profit. The company's net worth observed a substantial decline by a decrease of 44.78%.

Srini Pharmaceuticals revenue growth over time
Srini Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -18.31%
*******
*******
*******
*******
Revenue from Operations
*******
 -18.19%
*******
*******
*******
*******
Total Assets
*******
 -14.07%
*******
*******
*******
*******
Profit or Loss
*******
 -536.98%
*******
*******
*******
*******
Net Worth
*******
 -44.78%
*******
*******
*******
*******
EBITDA
*******
 -569.37%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Srini Pharmaceuticals?

In 2025, Srini Pharmaceuticals had a promoter holding of 119.00% and a public holding of 19.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,201,051,693.00

Satisfied Charges

₹805,800,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 114.11 Cr
  • Industrial Development Bank Of India Ltd : 3.75 Cr
  • State Bank Of Hyderabad : 2.25 Cr
Latest Charge Details
Date Lender Amount Status
23 Mar 2026 Hdfc Bank Limited ₹15.00 Cr Open
20 Mar 2025 Hdfc Bank Limited ₹2.09 Cr Open
14 Dec 2022 Hdfc Bank Limited ₹6.77 M Open
27 Oct 2021 Hdfc Bank Limited ₹1.37 Cr Open
25 Aug 2018 Hdfc Bank Limited ₹94.97 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Srini Pharmaceuticals?

Srini Pharmaceuticals has a workforce of 436 employees as of Sep 25, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Srini Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srini Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Srini Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 15.00 Cr with Charge ID 101258792 was registered on 23 Mar 2026. was documented.

  • Annual General Meeting

    Progress on Srini Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited of Rs. 94.97 Cr registered on 25 Aug 2018 with Charge ID 100203777 was modified on 26 Sep 2025. was completed.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 2.09 Cr with Charge ID 101071916 was registered on 20 Mar 2025. was completed.

  • Balance Sheet

    Srini Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    Progress on Ravali Reddy Tera was appointed as a Whole-time director was appointed as a Whole-time director on 26 Dec 2022 & has been associated with this company since 3 years 4 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Srini Pharmaceuticals Private Limited?

The CIN of Srini Pharmaceuticals Private Limited is U24231TG1995PTC019543.

Where is Srini Pharmaceuticals Private Limited headquartered?

Srini Pharmaceuticals Private Limited is headquartered at 8-2-293/82/F/10Plot No 10, Type - C Road No 8, Film Nagar, Hyderabad - 500 033, Telangana.

When was Srini Pharmaceuticals Private Limited incorporated?

Srini Pharmaceuticals Private Limited was incorporated on 24 February 1995.

Who are the current directors of Srini Pharmaceuticals Private Limited?

The current directors of Srini Pharmaceuticals Private Limited are

What is the primary industry of Srini Pharmaceuticals Private Limited?

The primary industry of Srini Pharmaceuticals Private Limited is Manufacturing.

Is Srini Pharmaceuticals Private Limited a listed company?

Srini Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Srini Pharmaceuticals Private Limited?

The authorized capital of Srini Pharmaceuticals Private Limited is ₹2.70 Cr, and the paid-up capital is ₹2.36 Cr.

What is the compliance status of Srini Pharmaceuticals Private Limited?

The compliance status of Srini Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available